Standard Investment buys DSM’s Synres division

The transaction is expected to close in Q1 2015.

Royal DSM is a Dutch life sciences and material sciences company. The group generated €9.6bn in revenues last year and EBITDA of €1.3bn. It employs 24,000 staff overall.

Royal DSM's Performance Materals cluster – in which Synres was located – generated €2.7bn in turnover and an EBITDA of €324m last year. It employs 5,100 staff.

Company
Founded in 1947 and headquartered in Hoek van Holland, DSM Synres is a producer of solvent-borne alkyd and acrylic coating resins.

Customers operate in the global coatings, adhesives and graphic arts markets. The company employs 80 staff and generates around €50m in revenues.

People
Feike Sijbesma is the chairman and CEO of Royal DSM.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Buyouts
• Industrials
• Netherlands